Comparative statistics by cancer registry
Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
(Karunagappally, India, 1991-1997 cases followed-up until 1999)Click on cancer site (ICD-10 code) for comparison
| Site | ICD-10 | Total | Absolute survival % | Relative survival % | ASRS% at 5-years | ||||||
| 1-year | 3-year | 5-year | 1-year | 3-year | 5-year | all ages | 0-74 years | ||||
| C01-02 | Tongue | 86 | 62.6 | 35.3 | 25.9 | 65.1 | 39.4 | 31.9 | 31.1 | 29.6 | |
| C03-06 | Oral cavity | 123 | 65.6 | 41.1 | 33.1 | 68.3 | 46.5 | 41.2 | 42.3 | 45.3 | |
| C12-13 | Hypopharynx | 33 | 62.5 | 29.6 | 12.6 | 64.3 | 32.0 | 14.6 | 18.4 | 15.5 | |
| C15 | Oesophagus | 106 | 27.0 | 3.9 | 2.9 | 28.3 | 4.4 | 3.5 | 14.1 | 18.5 | |
| C16 | Stomach | 77 | 22.1 | 5.2 | 2.6 | 23.1 | 5.9 | 3.3 | 3.0 | 4.1 | |
| C19-20 | Rectum | 38 | 76.3 | 49.4 | 26.5 | 79.2 | 55.7 | 33.4 | 43.6 | 32.6 | |
| C22 | Liver | 54 | 34.6 | 9.2 | 2.3 | 35.7 | 10.3 | 2.8 | 4.3 | 4.5 | |
| C25 | Pancreas | 41 | 12.2 | 2.4 | 2.4 | 12.6 | 2.7 | 3.0 | 2.8 | 4.3 | |
| C32 | Larynx | 46 | 69.6 | 33.3 | 29.6 | 72.5 | 37.2 | 35.1 | 32.3 | 28.3 | |
| C33-34 | Lung | 220 | 22.2 | 7.0 | 5.3 | 23.1 | 7.8 | 6.4 | 5.6 | 7.8 | |
| C44 | Other skin | 27 | 84.9 | 69.5 | 65.3 | 88.3 | 78.3 | 80.3 | 88.0 | 83.7 | |
| C50 | Breast | 190 | 85.8 | 59.0 | 46.8 | 87.2 | 62.2 | 51.2 | 44.8 | 54.4 | |
| C53 | Cervix | 170 | 82.9 | 59.4 | 46.7 | 85.7 | 66.0 | 56.3 | 54.8 | 57.8 | |
| C56 | Ovary | 35 | 62.9 | 36.4 | 26.0 | 64.1 | 38.3 | 28.1 | 24.1 | 27.8 | |
| C61 | Prostate | 32 | 93.5 | 49.0 | 22.1 | 101.2 | 63.3 | 34.6 | 41.1 | 32.6 | |
| C67 | Urinary bladder | 38 | 65.3 | 37.9 | 34.6 | 69.0 | 45.0 | 46.4 | 44.5 | 48.4 | |
| C70-72 | Brain & nervous system | 46 | 65.2 | 36.3 | 19.2 | 65.9 | 37.1 | 19.8 | 15.1 | 16.2 | |
| C73 | Thyroid | 74 | 91.8 | 84.7 | 81.2 | 93.6 | 89.5 | 88.2 | 86.0 | 90.0 | |
| C82-85+C96 | Non-Hodgkin lymphoma | 69 | 52.2 | 34.6 | 25.5 | 54.4 | 38.8 | 30.4 | 36.0 | 39.8 | |
| C90 | Multiple myeloma | 28 | 63.6 | 25.4 | 10.2 | 66.3 | 28.3 | 12.3 | 12.4 | 13.4 | |
| C91 | Lymphoid leukaemia | 38 | 60.5 | 36.3 | 36.3 | 61.1 | 37.0 | 37.1 | 36.3 | 45.6 | |
| C92-94 | Myeloid leukaemia | 30 | 30.0 | 16.0 | 8.0 | 30.5 | 16.4 | 8.3 | 6.7 | 8.2 | |
Graphs:
 |
Other tables available for this registry:
| - Table1: | Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Karunagappally, India, 1991-1997 cases followed-up until 1999) |
| - Table2a: | Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site (Karunagappally, India, 1991-1997 cases followed-up until 1999) |
| - Table3: | Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Karunagappally, India, 1991-1997 cases followed-up until 1999) |
| - Table4: | Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Karunagappally, India, 1991-1997 cases followed-up until 1999) |
| - Table5b: | Proportion (%) of cases and 5-year absolute survival by extent of disease and site (Karunagappally, India, 1991-1997) |
Registry chapter:
 | Consult the chapter in Cancer survival in developping countries (Volume II) |